DOSE- AND TIME-DEPENDENT DIURETIC EFFECTS OF KHAMZAABAD MUMIJO IN DOGS

Authors

  • Zagrutdinov Fanil Faridovich Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology. Author

Keywords:

Khamzaabad Mumijo; Shilajit; diuresis; diuretic activity; urine output; intravenous administration; renal function; conscious dogs.

Abstract

 The present study investigated the diuretic effect of Khamzaabad Mumijo in conscious female dogs. The experiment was designed to evaluate the influence of different intravenous doses of Mumijo on urine output over a 4-hour observation period. Urine samples were collected hourly, with the initial collection serving as the control period. Mumijo was administered intravenously at doses of 1, 5, 10, 25, and 50 mg/kg in 10 mL of 0.9% physiological saline. The results demonstrated a marked increase in urine output following Mumijo administration compared with the vehicle control. The diuretic response generally increased with dose and was most prominent between 2 and 3 hours after administration. The highest urine output was observed with 10 mg/kg at 3 hours (268.0 ± 6.4), while substantial responses were also recorded at 25 and 50 mg/kg. These findings indicate that Khamzaabad Mumijo possesses pronounced diuretic activity following intravenous administration. Further studies are required to clarify the underlying renal mechanisms and establish its optimal dose and safety.

References

1.Qi Z, Kelley E. The WHO Traditional Medicine Strategy 2014-2023: A perspective. Science. 2014;346:S5-S6.

2.“WHO Traditional Medicine Strategy 2014-2023”. World Health Organization Retrieved 2014-04-20. 2013.

3.Ghosal S. 2006. Shilajit in Perspective. Narosa Publishing House, New Delhi India.

4.Wilson E, Rajamanickam GV, Dubey GP,et al.2011. Review on shilajit used in traditional Indian medicine.J Ethnopharmacol 136:1–9

5.Schepetkin I, Khebnikov A, Kwon BS. 2002. Medical drugs from humus matter: focus on mumie.Drug Devel Res57: 140–159

6. Shirbeigi L ZA, Naghizadeh A, Alizadeh Vaghasloo M. The Concept of Temperaments in Traditional Persian Medicine. Trad Integr Med. 2017;2(3):143-56.

7. Frolova N, Kiseleva L, Tatiana. Chemical composition of mumijo and methods for determining its authenticity and quality (a review). Pharma Chem J. 1996;30(8):543-7.

8.Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: a review. Phytother Res. 2007;21(5):401-5.

9.Verma A, Kumar N, Gupta L, Chaudhary S. Shilajitin Cancer Treatment: Probable Mode of Action. Int J Pharmaceutic Bio Arch. 2016;7(1):12-6.

10. Stohs SJ, Singh K, Das A, Roy S, Sen CK. 12-Energy and Health Benefits of Shilajit. In: Bagchi D, editor. Sustained Energy for Enhanced Human Functions and Activity. Academic Press; 2017. p. 187-204

11.Ghosal S, Lal J, Singh SK, Goel RK, Jaiswal AK, Bhattacharya SK. The need for formulation of Shilajit by its isolated active constituents. Phytother Res. 1991;5(5):211-6

12.Trivedi N, Mazumdar B, Bhatt J, Hemavathi K. Effect of shilajit on blood glucose and lipid profile in alloxaninduced diabetic rats. Indian J Pharmacol. 2004;36(6):373-6.

Downloads

Published

2026-10-16